BRIEF-Generate Biomedicines And Zealand Pharma Enter Collaboration And License Agreement To Develop Protein Therapeutics Engineered With Ai For Metabolic Diseases

Generate Biomedicines Inc GENB.O:

• GENERATE BIOMEDICINES AND ZEALAND PHARMA ENTER COLLABORATION AND LICENSE AGREEMENT TO DEVELOP PROTEIN THERAPEUTICS ENGINEERED WITH AI FOR METABOLIC DISEASES

• GENERATE BIOMEDICINES - TO RECEIVE $30 MILLION UPFRONT, UP TO $1.20 BILLION IN MILESTONES, PLUS ROYALTIES

• GENERATE BIOMEDICINES - COLLABORATION TO DEVELOP MULTISPECIFIC PROTEIN THERAPEUTICS FOR OBESITY AND METABOLIC DISEASES

• GENERATE BIOMEDICINES - TO LEAD RESEARCH; ZEALAND PHARMA TO HANDLE CLINICAL DEVELOPMENT AND COMMERCIALIZATION

• GENERATE BIOMEDICINES - CO TO LEAD RESEARCH; ZEALAND PHARMA TO HANDLE CLINICAL DEVELOPMENT AND COMMERCIALIZATION

Source text: ID:nGNX9WNXY0

Further company coverage: GENB.O